Frontiers in Oncology | Hematologic Malignancies

Case Report

Published on 25 Sep 2025

Zanubrutinib as a salvage therapy for ibrutinib-resistant chronic lymphocytic leukemia: a case report

in Hematologic Malignancies

Zhenhui Lv
Ping Lu
Changhua Jing
Xuena Yi
Xueqiong Wu

Frontiers in Oncology

doi 10.3389/fonc.2025.1671124

466 views

Mini Review

Accepted on 24 Sep 2025

Anti-angiogenesis in human lymphomas. New insights

in Hematologic Malignancies

Domenico RIBATTI
Roberto Tamma
Giuseppe Ingravallo
Giorgina Specchia

Frontiers in Oncology

doi 10.3389/fonc.2025.1636332

186 views

Correction

Accepted on 24 Sep 2025

Correction: TARGETING RAB7 IN HUMAN B LYMPHOMA BY A SMALL MOLECULE INHIBITOR ARRESTS TUMOR CELL GROWTH

in Hematologic Malignancies

Maria Fernandez
Rui Wang
Jingwei Wang
Shuai Wu
Kenneth Holder
Alia Nazarullah
Ricardo Aguiar
Zijun Y. Xu-Monette
Ken Young
Hui Yan

Frontiers in Oncology

doi 10.3389/fonc.2025.1711784

158 views

Perspective

Accepted on 24 Sep 2025

Unmet needs in patients with acute myeloid leukemia ineligible for intensive approaches: perspectives from a European expert panel

in Hematologic Malignancies

Felicetto Ferrara
Klaus Geissler
Priyanka Mehta
Pau Montesinos
Adriano Venditti

Frontiers in Oncology

doi 10.3389/fonc.2025.1642472

179 views

Original Research

Accepted on 23 Sep 2025

Laboratory and Imaging Risk Factors for Mortality in Children with Primary Hemophagocytic Lymphohistiocytosis

in Hematologic Malignancies

Jia Huang
Sipei Xu
Rui Tang
Yan Huang
Wei Li
Chundan Gong
Sijie Gao
Hailun Peng
Li Xiao
MA WEI

Frontiers in Oncology

doi 10.3389/fonc.2025.1668762

214 views

Case Report

Published on 23 Sep 2025

Efficacy of brentuximab vedotin combined with sintilimab in relapsed/refractory DLBCL patient with secondary hemophagocytic syndrome: a case report and literature review

in Hematologic Malignancies

Siyu Cheng
Huihong Wu
Wenguang Bao
Zhigang Peng
Fengxiang Huang
Shengsheng Zhou
Qinli Mo
Ye Li
Yehong Bin
Dong Lan

Frontiers in Oncology

doi 10.3389/fonc.2025.1531713

556 views

Mini Review

Published on 23 Sep 2025

Immunoparesis in multiple myeloma: a current overview

in Hematologic Malignancies

Hongfeng Wang
Jianbin Chen

Frontiers in Oncology

doi 10.3389/fonc.2025.1628144

336 views

Review

Accepted on 22 Sep 2025

Research Advances in the Adjunctive Diagnosis of Acute Myeloid Leukemia

in Hematologic Malignancies

Wentao Xie
Xinye Jiang
Jingying Huang
Mingwei Qin
Zhisheng Bi

Frontiers in Oncology

doi 10.3389/fonc.2025.1634935

360 views

Case Report

Published on 22 Sep 2025

Erdheim-Chester disease: unveiling hidden manifestations through two case reports

in Hematologic Malignancies

Guoxia Zhang
Xiaoqing Yang
Lei Fang
Yuxia Cheng
Yanhua Duan
Jing Cui

Frontiers in Oncology

doi 10.3389/fonc.2025.1611907

349 views

Original Research

Published on 22 Sep 2025

Targeting RAB7 in human B lymphoma by a small molecule inhibitor arrests tumor cell growth

in Hematologic Malignancies

Maria Fernandez
Rui Wang
Jingwei Wang
Shuai Wu
Kenneth Holder
Alia Nazarullah
Ricardo C. T. Aguiar
Zijun Y. Xu-Monette
Ken H. Young
Hui Yan

Frontiers in Oncology

doi 10.3389/fonc.2025.1616519

735 views

Mini Review

Published on 22 Sep 2025

Lower dose and weekly schedules of selinexor in multiple myeloma - updated evidence on safety and efficacy

in Hematologic Malignancies

Muhamed Baljevic
Gary Schiller
Tomer M. Mark
Dane R. Van Domelen
Cristina Gasparetto

Frontiers in Oncology

doi 10.3389/fonc.2025.1649493

458 views

Systematic Review

Published on 19 Sep 2025

Prognostic and clinicopathological value of prognostic nutritional index in patients with multiple myeloma: a meta-analysis

in Hematologic Malignancies

Yanchen Nie
Zongxin Zhang
Xiaohuan Tang

Frontiers in Oncology

doi 10.3389/fonc.2025.1545096

2,252 views

Case Report

Published on 18 Sep 2025

Case Report: A chronic myeloid leukemia patient with e8a2 BCR::ABL1 fusion transcript was successfully treated with Flumatinib

in Hematologic Malignancies

Shanfeng Hao
Yao Zhang
Qing Shao
Lijuan Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1670115

808 views

Case Report

Published on 18 Sep 2025

Venetoclax as a cytoreduction therapy option for acute promyelocytic leukemia in newly diagnosed adult patients: a case report of a 35-year-old female with schizophrenia

in Hematologic Malignancies

Lingling Wang
Yuqing Miao
Yuexin Cheng

Frontiers in Oncology

doi 10.3389/fonc.2025.1671529

559 views

Case Report

Accepted on 17 Sep 2025

Uncommon co-occurrence of different renal histopathological entities in a patient with multiple myeloma and lymphoplasmacytic lymphoma: a case report

in Hematologic Malignancies

Marco Talarico
Gisella Vischini
Simona Barbato
Roberta Restuccia
Simone Masci
Ilaria Sacchetti
Enrica Manzato
Stefano Ghibellini
Michele Puppi
Miriam Iezza

Frontiers in Oncology

doi 10.3389/fonc.2025.1672690

558 views

Original Research

Accepted on 17 Sep 2025

Improvement of Revised International Staging System Risk Stratification in Patients with Newly Diagnosed Multiple Myeloma Using a High Bone Marrow Plasma Cell Percentage: A Real-World Study in China

in Hematologic Malignancies

Xiaoman Sun
Min Song
Pengyu Wang
Zhongmei Zhang
Jie Shi
Rongqin Dai

Frontiers in Oncology

doi 10.3389/fonc.2025.1627653

261 views